Scientific Sessions

Ethical considerations are fundamental in infectious disease research, clinical trials, and public health policy. This session explores informed consent, resource allocation, equity, and global collaboration challenges. Emphasis is placed on interdisciplinary dialogue between ethicists, clinicians, researchers, and policymakers. Case studies highlight real-world dilemmas and best practices. Attendees will discuss strategies for integrating ethical principles into research, clinical practice, and policy development.

Researchers and healthcare professionals are invited to submit one-page abstracts to Infectious Disease, Ethics and Global Health. Share insights guiding ethical practice and policy in infectious disease management.

Food-borne diseases remain a global public health challenge, requiring rapid detection and effective intervention. This session examines bacterial, viral, and parasitic food-borne infections, outbreak investigation strategies, and preventive measures. Emphasis is placed on collaboration between clinicians, epidemiologists, and public health authorities. Case studies highlight successful outbreak responses and lessons learned. Attendees will explore emerging technologies and policies for controlling food-borne illnesses.

Researchers and public health professionals are encouraged to submit one-page abstracts to Infectious Disease, Food Safety and Outbreak Management. Share strategies advancing food-borne disease prevention and control.

Aging impacts immune function, increasing susceptibility to infections and complications. This session examines immunosenescence, age-related infection risk, and vaccination strategies for older adults. Collaborative care approaches involving geriatricians, infectious disease specialists, and public health professionals are highlighted. Case studies will illustrate interventions improving outcomes in elderly populations. Attendees will explore emerging research and strategies for protecting vulnerable older adults.

Researchers and clinicians are invited to submit one-page abstracts to Infectious Disease, Geriatric Care and Immune Health. Share innovations improving infection prevention and management in older adults.

Rational antibiotic use is critical to combat antimicrobial resistance and improve patient outcomes. This session explores stewardship programs, monitoring strategies, and educational interventions in hospitals and community settings. Emphasis is placed on collaboration between clinicians, pharmacists, and public health professionals. Case studies highlight successful implementation and lessons learned. Attendees will explore innovative approaches for promoting responsible antibiotic use and improving clinical outcomes.

Researchers and healthcare professionals are encouraged to submit one-page abstracts to Infectious Disease, Antibiotic Stewardship and Clinical Practice. Share strategies advancing responsible antimicrobial use.

Influenza remains a major cause of global morbidity and mortality, with potential pandemic risk. This session examines seasonal epidemiology, strain evolution, vaccination strategies, and antiviral therapies. Collaborative approaches between clinicians, epidemiologists, and vaccine developers are emphasized. Case studies will illustrate successful prevention and control strategies. Attendees will explore emerging trends and challenges in influenza management and preparedness.

Researchers and clinicians are invited to submit one-page abstracts to Infectious Disease, Influenza and Pandemic Preparedness. Share research advancing influenza prevention and control.

Effective public health policy is essential for controlling infectious diseases. This session explores policy development, outbreak response strategies, and global health governance. Emphasis is placed on interdisciplinary collaboration between policymakers, clinicians, and public health officials. Case studies highlight successful interventions, communication strategies, and lessons learned from recent outbreaks. Attendees will discuss challenges and innovative approaches to improving public health preparedness.

Researchers and public health professionals are encouraged to submit one-page abstracts to Infectious Disease, Policy and Global Health. Share insights that shape effective public health strategies.

Respiratory infections remain a leading cause of morbidity and mortality worldwide. This session examines pathogens such as influenza, RSV, and bacterial pneumonias, including their epidemiology, diagnostics, and treatment strategies. Collaborative approaches between clinicians, epidemiologists, and public health experts are emphasized. Case studies will illustrate lessons learned in outbreak management and patient care. Attendees will explore emerging therapies and preventive interventions for respiratory infections.

Researchers and healthcare professionals are invited to submit one-page abstracts to Infectious Disease, Respiratory Pathogens and Clinical Practice. Share innovations improving respiratory infection management.

Clinical trials are essential for developing effective therapeutics, vaccines, and preventive interventions. This session examines trial design, implementation, and ethical considerations in infectious disease research. Emphasis is placed on collaboration among clinicians, researchers, and regulatory bodies to ensure robust and ethical studies. Case studies highlight innovative trial designs, lessons learned, and real-world impact. Attendees will explore strategies for improving trial efficiency and patient outcomes.

Researchers and clinicians are encouraged to submit one-page abstracts to Infectious Disease, Clinical Trials and Therapeutics. Share experiences advancing clinical research in infectious diseases.

Pathogen genomics and bioinformatics are transforming infectious disease research and outbreak response. This session explores genome sequencing, data analysis, and computational modeling to understand pathogen evolution, transmission, and resistance. Emphasis is placed on collaborative approaches integrating genomics, epidemiology, and clinical practice. Case studies highlight real-world applications in outbreak tracking and public health decision-making. Attendees will gain insight into innovative bioinformatics tools shaping infectious disease management.

Researchers and bioinformaticians are invited to submit one-page abstracts to Infectious Disease, Genomics and Computational Research. Share innovations applying genomics to clinical and public health challenges.

Equitable access to vaccines is critical for global health and disease prevention. This session examines challenges in vaccine distribution, logistics, and policy frameworks. Collaborative approaches between governments, NGOs, and industry are highlighted to improve coverage. Case studies of successful global vaccination campaigns will be presented. Attendees will discuss strategies to overcome barriers and promote equitable vaccine access worldwide.

Researchers, policymakers, and public health professionals are encouraged to submit one-page abstracts to Infectious Disease, Vaccine Distribution and Equity. Share innovations improving global vaccine access.

Children present unique challenges in infectious disease prevention, diagnosis, and management. This session focuses on pediatric-specific infections, vaccination strategies, and treatment approaches. Emphasis is placed on collaborative care models involving pediatricians, infectious disease specialists, and public health professionals. Case studies highlight successful interventions and lessons learned. Attendees will explore emerging research and innovative strategies to improve outcomes in pediatric populations.

Researchers and clinicians are invited to submit one-page abstracts to Infectious Disease, Pediatric Care and Clinical Innovation. Share strategies advancing pediatric infectious disease management

Arboviruses such as Zika, dengue, and chikungunya pose ongoing threats to public health globally. This session examines epidemiology, prevention strategies, and outbreak response efforts. Emphasis is placed on collaboration between clinicians, public health authorities, and researchers for rapid containment. Case studies of recent arbovirus outbreaks will illustrate lessons learned and successful interventions. Attendees will explore emerging tools for surveillance, vaccine development, and vector control.

Researchers and public health professionals are encouraged to submit one-page abstracts to Infectious Disease, Arboviruses and Global Health. Share innovations in prevention and response strategies.

The human microbiome plays a critical role in infection susceptibility, immune response, and overall health. This session explores microbiome dynamics, dysbiosis, and therapeutic interventions such as probiotics and microbiome-targeted therapies. Emphasis is placed on translational research bridging laboratory discoveries to clinical application. Collaborative approaches between microbiologists, clinicians, and bioinformaticians are highlighted. Attendees will review emerging evidence linking microbiome modulation to improved infection outcomes.

Researchers and clinicians are invited to submit one-page abstracts to Infectious Disease, Microbiome Research and Clinical Applications. Share discoveries shaping microbiome-targeted therapies.

Vector-borne diseases, including malaria, dengue, and Lyme disease, remain a major global health concern. This session explores vector ecology, disease surveillance, and control strategies. Emphasis is placed on multidisciplinary collaboration between entomologists, epidemiologists, and public health officials. Case studies demonstrate successful interventions, monitoring, and outbreak response strategies. Attendees will discuss challenges and innovative approaches for effective vector-borne disease management.

Researchers and public health professionals are encouraged to submit one-page abstracts to Infectious Disease, Vector-Borne Diseases and Control. Share innovations in surveillance and prevention strategies.

Healthcare-associated infections present ongoing challenges for patient safety. This session highlights infection prevention strategies, sterilization practices, and protocol implementation in hospitals and clinics. Emphasis is placed on interdisciplinary collaboration among clinicians, infection control specialists, and administrators. Attendees will review case studies, policy frameworks, and quality improvement initiatives to reduce infection rates. Lessons learned and best practices for sustaining infection control programs will also be discussed.

Researchers and clinicians are invited to submit one-page abstracts to Infectious Disease, Infection Control and Healthcare Safety. Share strategies that improve patient safety and infection prevention.

Developing effective antiviral therapies remains a high priority for emerging and persistent viral diseases. This session explores drug discovery, clinical development, and resistance mechanisms. Emphasis is placed on translational research linking laboratory findings to patient care. Collaborative approaches between virologists, pharmacologists, and clinicians are highlighted to accelerate antiviral innovation. Case studies illustrate successful strategies and lessons learned in therapy development.

Researchers and industry professionals are encouraged to submit one-page abstracts to Infectious Disease, Antiviral Research and Development. Share innovations in antiviral therapy and clinical application.

Innate immunity represents the first line of defense against pathogens and is critical for understanding disease susceptibility. This session examines innate immune mechanisms, pattern recognition, and cytokine signaling in human infections. Translational research linking immune responses to clinical outcomes will be discussed. Emphasis is placed on collaboration between immunologists, clinicians, and researchers to develop novel therapies. Attendees will explore advances in immunomodulation and their implications for patient care.

Researchers and healthcare professionals are invited to submit one-page abstracts to Infectious Disease, Immunology and Host Defense. Share discoveries advancing immune-based interventions.

Modeling and predictive epidemiology are critical tools for outbreak preparedness and response. This session explores computational models, data integration, and scenario planning to anticipate disease spread. Collaborative approaches between epidemiologists, data scientists, and public health officials are emphasized. Case studies illustrate how predictive modeling informs policy, resource allocation, and intervention strategies. Attendees will discuss successes, limitations, and future directions for pandemic preparedness.

Researchers and public health experts are encouraged to submit one-page abstracts to Infectious Disease, Epidemiology and Modeling. Share innovative modeling approaches for outbreak management.

Fungal infections are increasingly recognized as serious threats, especially in immunocompromised populations. This session focuses on epidemiology, diagnostic advancements, treatment strategies, and antifungal resistance. Clinical evidence and translational research will be discussed to guide patient care. Emphasis is placed on collaboration between infectious disease specialists, microbiologists, and pharmacists. Attendees will explore challenges and innovative approaches to improve outcomes in fungal infections.

Researchers and clinicians are invited to submit one-page abstracts to Infectious Disease, Mycology and Clinical Practice. Share insights that improve fungal infection management.

Understanding bacterial mechanisms of disease is essential for developing targeted therapies. This session explores bacterial virulence, host-pathogen interactions, and novel therapeutic targets. Emphasis is placed on interdisciplinary research translating basic science into clinical practice. Attendees will review case studies, emerging therapies, and strategies for overcoming antibiotic resistance. Collaborative approaches between microbiologists, clinicians, and pharmacologists are highlighted.

Researchers and healthcare innovators are encouraged to submit one-page abstracts to Infectious Disease, Bacterial Pathogenesis and Therapy. Share discoveries that advance bacterial disease management.

Malaria remains a major public health concern, particularly in endemic regions. This session highlights novel antimalarial drugs, vaccine development, vector control strategies, and integrated surveillance. Emphasis is placed on collaborative approaches between clinicians, researchers, and public health agencies. Attendees will examine epidemiological trends, challenges in implementation, and lessons from eradication programs. Translational and field research linking interventions to improved outcomes will also be discussed.

Researchers and public health professionals are invited to submit one-page abstracts to Infectious Disease, Malaria Research and Control. Share strategies and innovations for malaria eradication.

HIV/AIDS continues to pose significant challenges despite advances in therapy. This session explores antiretroviral therapy optimization, preventive interventions, vaccine development, and curative strategies. Emphasis is placed on translational research, global prevention programs, and collaborative multidisciplinary care. Attendees will gain insight into current successes, implementation challenges, and future directions for HIV management. Case studies highlight lessons learned from community-based programs and clinical trials.

Researchers and clinicians are encouraged to submit one-page abstracts to Infectious Disease, HIV/AIDS and Global Health. Share research that improves prevention and care outcomes.

Tuberculosis remains a leading cause of infectious disease morbidity and mortality worldwide. This session focuses on drug-resistant TB, diagnostic innovations, vaccination gaps, and public health strategies for control. Clinical, epidemiological, and translational research will be discussed, highlighting new treatment regimens and integrated care pathways. Collaborative approaches involving clinicians, researchers, and policymakers are emphasized to optimize patient outcomes. Attendees will explore global strategies to reduce TB incidence and improve treatment adherence.

Researchers and healthcare professionals are invited to submit one-page abstracts to Infectious Disease, Tuberculosis and Global Control. Share strategies and innovations improving TB care.

COVID-19 has highlighted the complexity of viral pandemics and long-term health impacts. This session explores post-viral complications, long COVID, and clinical management strategies. Emphasis is placed on evidence-based care pathways, interdisciplinary approaches, and lessons learned for future pandemic preparedness. Collaborative research between clinicians, epidemiologists, and public health experts will be discussed. Attendees will examine strategies for improving resilience, monitoring long-term outcomes, and preparing healthcare systems for future outbreaks.

Researchers and clinicians are encouraged to submit one-page abstracts to Infectious Disease, COVID-19 and Pandemic Preparedness. Share findings that advance care and readiness.

Rapid and accurate diagnostics are critical for controlling infectious diseases. This session highlights advances in molecular assays, point-of-care testing, biosensors, and AI-assisted diagnostic tools. Discussions will cover clinical implementation, validation studies, and practical challenges in diverse healthcare settings. Emphasis is placed on collaboration between clinicians, laboratory scientists, and technology developers to enhance patient care and outbreak response. Case studies demonstrate real-world applications and lessons learned.

Researchers and healthcare innovators are invited to submit one-page abstracts to Infectious Disease, Diagnostics and Clinical Innovation. Share breakthroughs in rapid disease detection.

Zoonotic diseases exemplify the interconnectedness of human, animal, and environmental health. This session explores integrated One Health strategies for surveillance, prevention, and control of infections originating in animals. Topics include collaborative frameworks between veterinarians, physicians, epidemiologists, and environmental scientists. Case studies of recent zoonotic outbreaks illustrate successes and lessons learned. Emphasis is placed on cross-sector communication, policy development, and research integration.

Researchers and practitioners are encouraged to submit one-page abstracts to Infectious Disease, One Health and Zoonoses. Share strategies for protecting human and animal populations.

Understanding host-pathogen interactions is essential for developing effective therapies and preventive strategies. This session examines the molecular and cellular mechanisms pathogens use to invade, evade, and manipulate human host responses. Clinical implications for disease progression, susceptibility, and treatment outcomes will be highlighted. Translational research linking basic science to patient care will be discussed. Collaborative approaches between clinicians, microbiologists, and immunologists are emphasized to advance therapeutic innovation.

Researchers and healthcare professionals are invited to submit one-page abstracts to Infectious Disease, Host-Pathogen Interactions and Translational Research. Share discoveries that improve patient care and treatment strategies.

Vaccination remains a cornerstone of infectious disease prevention, yet the field continues to evolve rapidly with novel technologies. This session focuses on cutting-edge vaccine platforms, including mRNA, viral vectors, and protein subunits, and their mechanisms of eliciting protective immune responses. Clinical evidence, safety considerations, and real-world implementation strategies will be discussed. Collaborative approaches between immunologists, clinicians, and public health experts are emphasized to optimize vaccine deployment. Attendees will explore current successes and ongoing challenges in rapid vaccine development, particularly during emerging infectious threats.

Researchers and industry professionals are encouraged to submit one-page abstracts to Infectious Disease, Vaccine and Public Health. Share innovations shaping the future of infectious disease prevention.

Antimicrobial resistance (AMR) threatens the effectiveness of modern medicine and public health worldwide. This session examines trends in bacterial, fungal, and parasitic resistance, highlighting surveillance strategies, stewardship programs, and innovative drug development approaches. Emphasis is placed on interdisciplinary collaboration among clinicians, microbiologists, and policymakers to curb resistance and improve patient outcomes. Challenges in implementation, including resource limitations and behavioral barriers, will also be explored.

Clinicians, researchers, and public health experts are invited to submit one-page abstracts to Infectious Disease, Antimicrobial Resistance and Stewardship. Share your strategies for combating AMR.

Emerging viral pathogens continue to pose significant threats to global health, requiring proactive surveillance and rapid response strategies. This session explores the biology, epidemiology, and transmission dynamics of newly identified viruses with epidemic or pandemic potential. Discussions will include host-pathogen interactions, zoonotic spillover, and the role of global health networks in early detection. Emphasis will be placed on preventive strategies, risk assessment, and translational research informing public health interventions. Case studies and clinical experiences highlight lessons learned from recent outbreaks.

Researchers and public health professionals are encouraged to submit one-page abstracts to Infectious Disease, Surveillance and Global Health. Share insights that advance our understanding and response to viral threats.